Core Insights - HIP-3 introduces a new market framework on Hyperliquid, allowing builders to create their own perpetual markets without prior approval from the core team [2][3][6] - The first HIP-3 oracle, Hyperstone, was launched by RedStone, enabling the deployment of perpetual markets based on oracle feeds [2][6] - The shift to oracle-based pricing enhances the platform's capability to support a wider range of assets, moving beyond the limitations of validator consensus [3][7] Hyperliquid and HIP-3 - Hyperliquid's infrastructure is decentralized and permissionless, but initially, the core team controlled contract listings [2] - HIP-3 allows for the creation of perpetual markets for virtually any asset, increasing market creativity and complexity [3][6] - The introduction of HIP-3 is expected to diversify the types of perpetual markets available on Hyperliquid [7] Role of Oracles - Trusted oracles are essential for maintaining accurate pricing in high-volume trading environments [4] - RedStone's HyperStone oracle can deliver over 1,300 asset price feeds, aggregating data from more than 50 sources [4][5] - Prior to its official launch, HyperStone successfully delivered over 103 million data updates on testnet markets tied to ETH, BTC, and Tesla stock [5] Market Dynamics - HIP-3 enables builders to launch markets without gatekeepers, contrasting with traditional markets that are tightly regulated [8] - The decentralized nature of crypto assets aligns well with the HIP-3 model, facilitating price discovery without centralized control [7][8]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Viewpoint - Biohaven's shares experienced a significant decline of over 40% following the U.S. Food and Drug Administration's decision to not approve its experimental treatment for a rare brain disorder [1] Company Summary - Biohaven's stock price fell more than 40% on Wednesday [1] - The decline was triggered by the FDA's rejection of its experimental treatment [1] Industry Summary - The news highlights the challenges faced by companies in the pharmaceutical industry, particularly in the approval process for new treatments [1]

Key Takeaways Norwegian Cruise Line's Q3 EPS rose to $1.20, topping estimates and up from $1.02 a year earlier.Quarterly revenues grew 4.7% to $2.94B, driven by strong demand and record third-quarter bookings.NCLH raised full-year EPS outlook and reaffirmed EBITDA guidance on solid travel momentum.Norwegian Cruise Line Holdings (NCLH) delivered a year-over-year increase in third-quarter 2025 earnings and revenues, marked by strong demand trends and record bookings. The company’s adjusted earnings per share ...

Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF (IHE) on radar now. The fund recently hit a new 52-week high. Shares of IHE are up approximately 29.6% from their 52-week low of $58.97/share.But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.IHE In FocusThe underlying Dow Jones U.S. Select Pharmaceuticals Index is free-float adjusted market capitalization-weighted index. It includes ph ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Inspired Entertainment (INSE) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.67%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.19, delivering a surprise of -850%.Over the last four quarters, the company ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Royal Caribbean (RCL) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this cruise operator have returned -18.2%, compared to the Zacks S&P 500 composite's +1% change. During this period, the Zacks Leisure and Recreation Services industry, which Royal Caribbean falls in, has lost 8.8%. The key question now is: What could be the stock's ...